Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 1,730.4% in February

Aclarion, Inc. (NASDAQ:ACON) saw a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 247,100 shares, a growth of 1,730.4% from the January 31st total of 13,500 shares. Based on an average daily volume of 378,900 shares, the short-interest ratio is currently 0.7 days.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on ACON shares. Ascendiant Capital Markets cut their price target on Aclarion from $502.50 to $435.50 and set a “buy” rating on the stock in a research report on Wednesday, November 27th. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a report on Friday, December 13th.

Aclarion Trading Up 27.4 %

ACON opened at $3.35 on Friday. The firm has a fifty day moving average price of $15.68 and a 200 day moving average price of $45.39. Aclarion has a 1 year low of $2.43 and a 1 year high of $231.15.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.